Correction to: 1-13C-propionate breath testing as a surrogate endpoint to assess efficacy of liver-directed therapies in methylmalonic acidemia (MMA)

作者：Irini Manoli, Alexandra Pass, Elizabeth A. Harrington, Jennifer L. Sloan, Jack Gagné, Samantha McCoy, Sarah Bell, Jacob D. Hattenbach, Brooks P. Leitner, Courtney J. Duckworth, Laura A. Fletcher, Thomas M. Cassimatis, Carolina I. Galarreta, Audrey Thurm, Joseph Snow, Carol Van Ryzin, Susan Ferry, Nicholas Ah Mew, Oleg A. Shchelochkov, Kong Y. Chen, Charles P. Venditti · 发表于：Genetics in Medicine · 年份：2021 · DOI：10.1038/s41436-021-01188-9 · 被引用次数：10 · 研究领域：Metabolism and Genetic Disorders、Metabolomics and Mass Spectrometry Studies、Folate and B Vitamins Research

The original article can be found online at https://doi.org/10.1038/s41436-021-01143-8. Correction to: Genetics in Medicine 2021; https://doi.org/10.1038/s41436-021-01143-8; published online 05 April 2021 Due to a processing error, the online graphical abstract was not given. The original article has been corrected. 1-13C-propionate breath testing as a surrogate endpoint to assess efficacy of liver-directed therapies in methylmalonic acidemia (MMA)Genetics in MedicineVol. 23Issue 8PreviewTo develop a safe and noninvasive in vivo assay of hepatic propionate oxidative capacity. Full-Text PDF Open Access